Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralesional Bevacizumab for Airway Kaposi's Sarcoma
NCT01296815Phase 2Completed
- Sponsor
- Centro de Investigación en Enfermedades Infecciosas
- Start
- Sep 2010
- Primary completion
- Dec 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in Kaposi sarcoma (KS), sponsored by Centro de Investigación en Enfermedades Infecciosas. Started Sep 2010; status: completed.
02
Drugs
bevacizumab
03
Conditions
Kaposi sarcoma (KS)
Beyond the preview
Go deeper on NCT01296815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01296815.